# Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars

> **NCT02161354** · PHASE2 · TERMINATED · sponsor: **NanoSHIFT LLC** · enrollment: 52 (actual)

## Conditions studied

- Dental Pain

## Interventions

- **DRUG:** NTC-510 capsules
- **DRUG:** Placebo Capsules
- **DRUG:** NTC-510A Capsules

## Key facts

- **NCT ID:** NCT02161354
- **Lead sponsor:** NanoSHIFT LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** safety and efficacy after cohort 5 did not warrant further dose escalation
- **Last updated:** 2017-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02161354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02161354, "Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02161354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*